Buffett's Berkshire Hathaway Enters New Stake in Teva (TEVA), Adds to Apple (AAPL), BofA (BAC) (more...) - 13F
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Kraft Heinz (KHC) Misses Q4 EPS by 5c, Miss on Revenues
February 16, 2018 7:06 AM ESTKraft Heinz (NASDAQ: KHC) reported Q4 EPS of $0.90, $0.05 worse than the analyst estimate of $0.95. Revenue for the quarter came in at $6.88 billion versus the consensus estimate of $6.92 billion.
Q4 net sales increased 0.3%; Organic Net Sales(1) decreased 0.6%Q4 net income attributable to common shareholders... MoreApple (AAPL) Adds to Recent Gains, Up 3.1%
February 15, 2018 2:18 PM ESTApple (NASDAQ: AAPL) Adds to Recent Gains, Up 3.1%
... MoreThe Oracle of Omaha Goes Value Shopping in the Value Pharmaceutical Bin with Teva (TEVA)
February 15, 2018 12:26 PM ESTWith countless missteps, U.S. generics business weakness, Copaxone generic competition, and an ongoing restructuring, Teva Pharma (NYSE: TEVA) has been labeled your classic "dog" stock for the past couple of years. That all changed yesterday when Warren Buffett's Berkshire Hathaway shocked Wall Street by disclosing in their December-quarter 13F that they had accumulated a new, nearly 19 million share position in the Isreal-based pharmaceutical company.
While it is unclear if the Oracle himself pulled the trigger on the trade, all of Berkshire's lieutenants try to stick to... More
Citi Remains Bullish on Teva Pharma (TEVA) Amid Buffett Stake
February 15, 2018 7:18 AM ESTCiti reiterated a Buy rating and $24.00 price target on Teva Pharma (NYSE: TEVA) following the company's 13-F filing. Berkshire Hathaway reported a new stake of 18.9mn shares in TEVA, representing a total investment of ~$360mn at current levels.
Analyst Liav Abraham... More
